Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
A UNIQUE EXPLORATION OF GAME WRITING ROLLS INTO THE AMERICAN WRITERS MUSEUM
-
Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
-
Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Technology
-
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
-
Astiva Health Summer Gala: An Inaugural Celebration
-
Billor Fulfills the American Dream by Turning Truck Drivers into Entrepreneurs with Fintech and AI
-
Safe Harbor Financial Announces New Small Business Line of Credit Program with the Origination of Three New Lines of Credit
-
Bluejay Therapeutics Presents Positive Preliminary BJT-778 Data from Phase 2 Clinical Trial in Chronic Hepatitis D at EASL 2024 Congress
-
73% of Millennials Plan to Indulge in Self-Gifting This Holiday Season
-
Byrna Technologies Announces Record Preliminary Q2 2024 Results: Revenues Exceed $20 Million; Q2 Production Totals Over 48,000 Units
-
Equip’s Second Annual Report Highlights First-Rate Patient Outcomes, Company Growth
-
Iterum Therapeutics to Present Data at ASM Microbe 2024
-
Survey: B2B Web Store Woes Drive Manufacturing Buyers Elsewhere
-
Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts
-
Mediktor Acquires Sensely and Consolidates Its Position as a Leader in AI Healthcare Solutions
-
OKX Ventures Announces Strategic Investment in GoPlus to Enhance Blockchain Security
-
SDVerse Leverages Spryker to Drive the Future of Software-Defined Vehicles
-
Acorn Secures $5M Contract with Leading Wireless Provider for Remote Monitoring and Control of Cell Tower Backup Generators
-
MegaWatt Metals Provides Overview of Canada’s Uranium Mining Market & Significant Undiscovered Deposits
-
HF Fund: Auction results for LSS150434
-
Acreage Enters into US$10MM Private Placement
-
WOOFi Launches 395,000 ARB Incentives for its Users
-
TRYX to Showcase New Products at Computex 2024 in Taipei
-
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
-
Alaska Energy Metals Closes Option to Acquire the Bambino Nickel – Copper Property and Commences Exploration Programs on Its Quebec Properties
-
Pre-Commissioning of Fumed Silica Reactor Pilot Plant Underway
-
Fireweed Launches Largest Regional Exploration Campaign at Macpass
-
Ocular Therapeutix® to Host Investor Day on June 13, 2024
-
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Estate Conference
-
Ollie’s Bargain Outlet Reports First Quarter Fiscal 2024 Financial Results
-
Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That Helps Companies Launch A D2C Healthcare Brand In All 50 States
-
Ocean Power Technologies Awarded Contract for Immediate Delivery of Unmanned Surface Vehicle to Offshore Construction Contractor
-
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
-
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Estate Conference
-
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
Telix Announces Launch of Proposed Initial Public Offering in the United States
-
Ollie’s Bargain Outlet Announces Executive Promotions and Appointments as Part of Anticipated Leadership Succession
-
Fortuna Announces Offering of Convertible Senior Notes
-
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer
-
Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of Shareholders
-
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million
-
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, fo
-
SummerSeries in Trillium Park Returns at Ontario Place
-
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
AutoZone Vendor Summit Recognizes Contributions of Top Suppliers
-
Lifeist Sells Australian Vapes
-
West Red Lake Gold Outlines 2024 Madsen Mine Plans
-
Altimmune Presents Data at EASL International Liver Congress™ 2024 Supporting the Disease Modifying Potential and Differentiated Therapeutic Profile of Pemvidutide in Metabolic Dysfunction-Associate
-
Atea Pharmaceuticals Presents Positive Initial Phase 2 Data for Bemnifosbuvir and Ruzasvir Combination for Treatment of Hepatitis C Virus at EASL Congress 2024
